Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-30

Clinical Trial Update: Transdermal Basal Insulin Patch Study in Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of a transdermal basal insulin patch for Type 1 diabetes mellitus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal Basal Insulin Patch (insulin transdermal patch)

Snippet

Sponsor: Altea Therapeutics | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-12-30